Comparative Study Between Rezum and Tamsulosin

Comparison Between Convective Radiofrequency Water Vapor Thermal Ablation (REZUM) Versus Tamsulosin in Management of Lower Urinary Tract Symptoms in Patients With Benign Prostatic Enlargement

the investigators aimed to compare the efficacy and safety of Rezūm therapy for the management of benign prostatic hyperplasia (BPH) with Tamsulosin.

So far, data from available studies point towards good clinical outcomes with a short-term risk of self-limiting minor complications. Its application has demonstrated clinical effectiveness and possesses specific benefits that distinguish it among other treatments. It is applicable to outpatient setting, is effective in preserving sexual function and is versatile in its ability to treat a variety of prostate gland morphology.

Inclusion Criteria:

1. with prostate volumes of 30- 80 mL,
2. mild to mod LUTS
3. (maximum urinary flow rate [Q max] of <15 mL/s
4. International Prostate Symptom Score [IPSS] of >13)
5. PVR urine < 250 ml

Exclusion Criteria:

1. prostate cancer,
2. neurogenic bladder
3. urethral stricture,
4. urinary bladder stone
5. previous prostatic surgery